Fusion Pharmaceuticals Inc.
NASDAQ:FUSN
21.55 (USD) • At close June 3, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 33.636 | 2.006 | 0.034 | 0.028 | 0.14 | 0.166 | 0.57 | 0.585 | 0.594 | 0.325 | 0.521 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.361 | 0.361 | 1.044 | 0.931 | 15.877 | 17.607 | 16.551 | 12.076 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.361 | 33.275 | 0.962 | -0.897 | -15.849 | -17.467 | -16.385 | -11.506 | 0.585 | 0.594 | 0.325 | 0.521 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0.989 | 0.48 | -26.382 | -566.036 | -124.764 | -98.705 | -20.186 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 20.951 | 20.286 | 14.585 | 18.994 | 15.877 | 17.607 | 16.551 | 12.076 | 12.661 | 11.811 | 12.684 | 21.146 | 10.716 | 4.96 | 4.529 | 3.325 | 4.377 | 3.416 | 2.238 | 2.137 | 2.841 |
| General & Administrative Expenses
| 14.548 | 7.628 | 6.81 | 7.753 | 9.006 | 6.95 | 7.42 | 7.781 | 8.449 | 6.336 | 7.156 | 6.642 | 6.964 | 6.639 | 5.79 | 3.988 | 4.327 | 2.724 | 1.922 | 1.771 | 1.171 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 14.548 | 7.628 | 6.81 | 7.753 | 9.006 | 6.95 | 7.42 | 7.781 | 8.449 | 6.336 | 7.156 | 6.642 | 6.964 | 6.639 | 5.79 | 3.988 | 4.327 | 2.724 | 1.922 | 1.771 | 1.171 |
| Other Expenses
| 0.297 | 0.436 | 0.391 | 0.08 | -0.145 | -0.68 | -1.159 | -0.414 | 0.478 | 0.063 | 0.027 | 0.331 | 0.048 | 0.859 | 0.02 | -31.279 | -1.315 | -2.253 | 3.456 | 0.278 | 0.049 |
| Operating Expenses
| 35.499 | 27.914 | 21.395 | 26.747 | 24.883 | 24.557 | 23.971 | 19.857 | 21.11 | 18.147 | 19.84 | 27.788 | 17.68 | 11.738 | 10.278 | 7.261 | 8.658 | 6.096 | 4.116 | 3.864 | 3.968 |
| Operating Income
| -35.86 | -28.275 | -19.389 | -26.713 | -24.855 | -24.417 | -23.805 | -19.287 | -20.525 | -17.553 | -19.515 | -27.267 | -17.68 | -11.599 | -10.319 | -7.313 | -8.704 | -6.14 | -4.16 | -3.908 | -4.012 |
| Operating Income Ratio
| 0 | -0.841 | -9.666 | -785.676 | -887.679 | -174.407 | -143.404 | -33.837 | -35.085 | -29.551 | -60.046 | -52.336 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.953 | 1.392 | 1.884 | 0.08 | 0.553 | -0.54 | -0.969 | -0.467 | 0.561 | 0.063 | 0.027 | 0.331 | 0.048 | 0.859 | 0.02 | -37.344 | -1.649 | -2.253 | 3.456 | 0.278 | 0.049 |
| Income Before Tax
| -33.907 | -26.883 | -17.505 | -25.42 | -24.302 | -24.957 | -24.774 | -19.754 | -19.964 | -17.409 | -19.381 | -26.839 | -17.536 | -10.801 | -10.178 | -44.583 | -10.16 | -8.168 | -0.413 | -3.438 | -3.919 |
| Income Before Tax Ratio
| 0 | -0.799 | -8.726 | -747.647 | -867.929 | -178.264 | -149.241 | -34.656 | -34.126 | -29.308 | -59.634 | -51.514 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.237 | 1.296 | -0.253 | -0.245 | -0.011 | -0.34 | -0.761 | -0.681 | -0.055 | -0.173 | 0.048 | 0.014 | -0.007 | 2.584 | -0.185 | 0.15 | 0.062 | 0.038 | 0.181 | 0.018 | 0.014 |
| Net Income
| -33.67 | -28.179 | -17.252 | -25.175 | -24.291 | -24.617 | -24.013 | -19.073 | -19.909 | -17.236 | -19.429 | -26.853 | -17.529 | -13.385 | -9.993 | -44.733 | -10.222 | -8.206 | -0.594 | -3.456 | -3.933 |
| Net Income Ratio
| 0 | -0.838 | -8.6 | -740.441 | -867.536 | -175.836 | -144.657 | -33.461 | -34.032 | -29.017 | -59.782 | -51.541 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.4 | -0.39 | -0.25 | -0.38 | -0.45 | -0.55 | -0.55 | -0.44 | -0.46 | -0.4 | -0.45 | -0.63 | -0.42 | -0.32 | -0.24 | -18.91 | -0.25 | -0.39 | -0.028 | -0.16 | -0.18 |
| EPS Diluted
| -0.4 | -0.39 | -0.25 | -0.38 | -0.45 | -0.55 | -0.55 | -0.44 | -0.46 | -0.4 | -0.45 | -0.63 | -0.42 | -0.32 | -0.24 | -18.91 | -0.25 | -0.39 | -0.028 | -0.16 | -0.18 |
| EBITDA
| -35.499 | -27.914 | -19.389 | -23.801 | -23.079 | -23.788 | -23.563 | -19.071 | -20.322 | -17.553 | -19.33 | -27.113 | -17.569 | -11.738 | -10.175 | -1.098 | -8.152 | -6.019 | -4.037 | -3.793 | -3.905 |
| EBITDA Ratio
| 0 | -0.83 | -9.666 | -700.029 | -824.25 | -169.914 | -141.946 | -33.458 | -34.738 | -29.551 | -59.477 | -52.04 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |